Header Logo

Connection

KEVIN ERICKSON to United States

Back to Details
This is a "connection" page, showing publications KEVIN ERICKSON has written about United States.
KEVIN ERICKSON
Connection Strength
1.785
United States
  1. Facility Closures and Distance Traveled to Receive Dialysis Care in the United States. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1610-1612.
    View in: PubMed
    Score: 0.068
  2. Considering the Effects of a Recent US Supreme Court's Ruling on Dialysis Care Costs. Clin Ther. 2023 03; 45(3):272-276.
    View in: PubMed
    Score: 0.066
  3. Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
    View in: PubMed
    Score: 0.066
  4. The US Supreme Court and Future of Financing Dialysis Care. Clin J Am Soc Nephrol. 2023 02 01; 18(2):273-275.
    View in: PubMed
    Score: 0.066
  5. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.064
  6. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
    View in: PubMed
    Score: 0.062
  7. The beneficial effect of providing kidney transplantation information on transplantation status differs between for-profit and nonprofit dialysis centers. Transpl Int. 2021 12; 34(12):2644-2668.
    View in: PubMed
    Score: 0.061
  8. How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets? JAMA Health Forum. 2021 11 02; 2(11):e213378.
    View in: PubMed
    Score: 0.061
  9. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.060
  10. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.059
  11. ACOs and Bending the Cost Curve for Health Care Spending for People with Kidney Failure. Clin J Am Soc Nephrol. 2020 12 07; 15(12):1699-1701.
    View in: PubMed
    Score: 0.057
  12. Payer Mix Among Patients Receiving Dialysis. JAMA. 2020 09 01; 324(9):900-901.
    View in: PubMed
    Score: 0.056
  13. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.054
  14. Physician reimbursement for outpatient dialysis care: Past, present, and future. Semin Dial. 2020 01; 33(1):68-74.
    View in: PubMed
    Score: 0.054
  15. Consolidation in dialysis Markets-Causes, consequences, and the role of policy. Semin Dial. 2020 01; 33(1):90-99.
    View in: PubMed
    Score: 0.053
  16. The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
    View in: PubMed
    Score: 0.053
  17. Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
    View in: PubMed
    Score: 0.053
  18. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127.
    View in: PubMed
    Score: 0.052
  19. Expanded Prospective Payment System and Use of and Outcomes with Home Dialysis by Race and Ethnicity in the United States. Clin J Am Soc Nephrol. 2019 08 07; 14(8):1200-1212.
    View in: PubMed
    Score: 0.052
  20. Nephrology Advanced Practitioners in the United States, 2010-2018. Clin J Am Soc Nephrol. 2019 09 06; 14(9):1381-1382.
    View in: PubMed
    Score: 0.052
  21. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
    View in: PubMed
    Score: 0.050
  22. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
    View in: PubMed
    Score: 0.049
  23. Making Policy in the Dark: The Use of Activated Vitamin D Under Bundled Payments for Dialysis?Care. Am J Kidney Dis. 2018 08; 72(2):161-163.
    View in: PubMed
    Score: 0.048
  24. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.048
  25. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
    View in: PubMed
    Score: 0.048
  26. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.046
  27. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.042
  28. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.038
  29. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.036
  30. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8.
    View in: PubMed
    Score: 0.033
  31. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.033
  32. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013 Jan; 8(1):75-81.
    View in: PubMed
    Score: 0.032
  33. Optimal Care for Kidney Health: Development of a Merit-based Incentive Payment System (MIPS) Value Pathway. J Am Soc Nephrol. 2023 08 01; 34(8):1315-1328.
    View in: PubMed
    Score: 0.017
  34. Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery. J Am Soc Nephrol. 2020 03; 31(3):602-614.
    View in: PubMed
    Score: 0.013
  35. Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Res. 2020 02; 174:104698.
    View in: PubMed
    Score: 0.013
  36. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.012
  37. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.012
  38. Market Competition and Health Outcomes in Hemodialysis. Health Serv Res. 2018 10; 53(5):3680-3703.
    View in: PubMed
    Score: 0.012
  39. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.012
  40. Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health. 2016 Mar; 106(3):406-7.
    View in: PubMed
    Score: 0.010
  41. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.